Cancer screening in Japan 2 years after the COVID-19 pandemic: Changes in participation, 2017-2021.

ABSTRACT:

Objectives

The impact of the coronavirus disease (COVID-19) pandemic on cancer screening has become a global concern; compared with pre-pandemic levels, the number of individuals who underwent population-based cancer screening in Japan decreased by 10-30% in fiscal year (FY)2020. Therefore, it is important to monitor subsequent changes in the number of participants.

Methods

This descriptive study analysed data from a national database to determine changes from 2017 to 2021 in the number of people screened for gastric cancer (upper gastrointestinal [UGI] series or endoscopy), colorectal cancer (faecal immunochemical test), lung cancer (chest X-ray), breast cancer (mammography), and cervical cancer (Pap smear).

Results

Compared with the pre-pandemic period (FY 2017-2019

SUBMITTER: Machii R 

PROVIDER: S-EPMC10875236 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature